The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
PolyPid Ltd(NASDAQ:PYPD)


PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product includes D-PLEX100, which is in Phase 3 clinical trial for the prevention of sternal (bone) s...
Website: http://www.polypid.com
Founded: 2008
Full Time Employees: 57
CEO: Amir Weisberg
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
PolyPid Op Cashflow Per Share ttm
PolyPid Free Cashflow Per Share ttm
PolyPid Cash Per Share ttm
PolyPid (GAAP) P/E ratio ttm
PolyPid P/B ratio ttm
No extra charts and metrics for this ticker.